1. Home
  2. NVCR vs SONO Comparison

NVCR vs SONO Comparison

Compare NVCR & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • SONO
  • Stock Information
  • Founded
  • NVCR 2000
  • SONO 2002
  • Country
  • NVCR Jersey
  • SONO United States
  • Employees
  • NVCR N/A
  • SONO N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • SONO Consumer Electronics/Video Chains
  • Sector
  • NVCR Health Care
  • SONO Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • SONO Nasdaq
  • Market Cap
  • NVCR 1.8B
  • SONO 1.4B
  • IPO Year
  • NVCR 2015
  • SONO 2018
  • Fundamental
  • Price
  • NVCR $17.49
  • SONO $12.96
  • Analyst Decision
  • NVCR Buy
  • SONO Hold
  • Analyst Count
  • NVCR 5
  • SONO 3
  • Target Price
  • NVCR $26.60
  • SONO $15.67
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • SONO 1.3M
  • Earning Date
  • NVCR 10-30-2024
  • SONO 11-13-2024
  • Dividend Yield
  • NVCR N/A
  • SONO N/A
  • EPS Growth
  • NVCR N/A
  • SONO N/A
  • EPS
  • NVCR N/A
  • SONO N/A
  • Revenue
  • NVCR $549,964,000.00
  • SONO $1,567,823,000.00
  • Revenue This Year
  • NVCR $16.23
  • SONO N/A
  • Revenue Next Year
  • NVCR $6.09
  • SONO N/A
  • P/E Ratio
  • NVCR N/A
  • SONO N/A
  • Revenue Growth
  • NVCR 8.33
  • SONO N/A
  • 52 Week Low
  • NVCR $10.87
  • SONO $10.10
  • 52 Week High
  • NVCR $24.74
  • SONO $19.76
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • SONO 60.67
  • Support Level
  • NVCR $15.61
  • SONO $12.76
  • Resistance Level
  • NVCR $17.31
  • SONO $13.19
  • Average True Range (ATR)
  • NVCR 1.29
  • SONO 0.36
  • MACD
  • NVCR 0.05
  • SONO 0.06
  • Stochastic Oscillator
  • NVCR 11.59
  • SONO 93.84

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About SONO Sonos Inc.

Sonos Inc is engaged in providing home sound systems. The company's product profile includes speaker sets and other accessories like boost, mounts, stands, and cables and networking. Geographically, the company operates in the Americas, Europe, the Middle East and Africa, and the Asia Pacific. Generating a majority of its revenue from the Americas.

Share on Social Networks: